GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biome Australia Ltd (ASX:BIO) » Definitions » LT-Debt-to-Total-Asset

Biome Australia (ASX:BIO) LT-Debt-to-Total-Asset : 0.01 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Biome Australia LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Biome Australia's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.01.

Biome Australia's long-term debt to total assets ratio declined from Dec. 2023 (0.04) to Dec. 2024 (0.01). It may suggest that Biome Australia is progressively becoming less dependent on debt to grow their business.


Biome Australia LT-Debt-to-Total-Asset Historical Data

The historical data trend for Biome Australia's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biome Australia LT-Debt-to-Total-Asset Chart

Biome Australia Annual Data
Trend Jun22 Jun23 Jun24
LT-Debt-to-Total-Asset
0.05 0.12 0.02

Biome Australia Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial 0.04 0.12 0.04 0.02 0.01

Biome Australia LT-Debt-to-Total-Asset Calculation

Biome Australia's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (A: Jun. 2024 )=Long-Term Debt & Capital Lease Obligation (A: Jun. 2024 )/Total Assets (A: Jun. 2024 )
=0.168/8.277
=0.02

Biome Australia's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )/Total Assets (Q: Dec. 2024 )
=0.111/10.436
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biome Australia  (ASX:BIO) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Biome Australia LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Biome Australia's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Biome Australia Business Description

Traded in Other Exchanges
N/A
Address
192-194 Johnston Street, Collingwood, VIC, AUS, 3066
Biome Australia Ltd licences, develops, and markets evidence-based, complementary medicines, including nutraceuticals food-based vitamins and weight management products and live biotherapeutics. The firm owns brands namely; Activated Nutrients: a range of completely organic, plant-based, all-in-one nutritional products; Activated Probiotics: a first-of-its-kind range of clinically-backed precision probiotics. The company has one operating segment: researching, developing, manufacturing and distributing innovative evidence-based products linking the gut and human health. Domestically it caters to Australia and In international markets, the Group distributes and markets its Activated Probiotics range in the United Kingdom and New Zealand through independent health practitioners.